FMP

FMP

Enter

EMMA - Emmaus Life Sciences...

Financial Summary of Emmaus Life Sciences, Inc.(EMMA), Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, marke

photo-url-https://financialmodelingprep.com/image-stock/EMMA.png

Emmaus Life Sciences, Inc.

EMMA

PNK

Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California.

0.09211 USD

-0.0216 (-23.45%)

About

ceo

Mr. Willis C. Lee M.S.

sector

Healthcare

industry

Biotechnology

website

https://www.emmausmedical.com

exchange

PNK

Description

Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. Emmaus ...

CIK

0000822370

ISIN

US29137T1016

CUSIP

29137T101

Address

21250 Hawthorne Boulevard

Phone

310 214 0065

Country

US

Employee

54

IPO Date

May 9, 2000

Summary

CIK

0000822370

Exchange

PNK

Industry

Biotechnology

Sector

Healthcare

CUSIP

29137T101

ISIN

US29137T1016

Country

US

Price

0.09

Beta

1.7

Volume Avg.

11.37k

Market Cap

4.94M

Shares

-

52-Week

0.051-0.34

DCF

1.15

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.15

P/B

-

Website

https://www.emmausmedical.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest EMMA News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep